• Pharmacology
  • Allergy, Immunology, and ENT
  • Cardiology
  • Emergency Medicine
  • Endocrinology
  • Adolescent Medicine
  • Gastroenterology
  • Infectious Diseases
  • Neurology
  • OB/GYN
  • Practice Improvement
  • Gynecology
  • Respiratory
  • Dermatology
  • Mental, Behavioral and Development Health
  • Oncology
  • Rheumatology
  • Sexual Health
  • Pain

Happenings on the vaccine front

Article

Two items of note can be considered good news. First, there is more reassurance for parents about thimerosal and measles-mumps-rubella (MMR) vaccine: In mid-May, the Immunization Safety Review Committee of the Institute of Medicine issued a final report on a purported connection between autism and the MMR vaccine and other thimerosal-containing vaccines. The committee's conclusion? Epidemiologic evidence doesn't support any connection.

Second, the supply of the conjugate pneumococcal vaccine (PCV7, Prevnar) is catching up with CDC requirements for its administration, and dosing restrictions may be lifted soon. According to CDC National Vaccine Program Office Medical Director Gregory Wallace, "current projections suggest that supply will be adequate for a three-dose coverage in the summer and a four-dose coverage in the fall." Wyeth, the vaccine's sole manufacturer, has been plagued by manufacturing problems but says that its "significant investment" in production facilities should avert shortages in the future.

Related Videos
Venous thromboembolism, Heparin-induced thrombocytopenia, and direct oral anticoagulants | Image credit: Contemporary Pediatrics
Jessica Peck, DNP, APRN, CPNP-PC, CNE, CNL, FAANP, FAAN
Sally Humphrey, DNP, APRN, CPNP-PC | Image Credit: Contemporary Pediatrics
Ashley Gyura, DNP, CPNP-PC | Image Credit: Children's Minnesota
Congenital heart disease and associated genetic red flags
Traci Gonzales, MSN, APRN, CPNP-PC
Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN
Scott Ceresnak, MD
© 2024 MJH Life Sciences

All rights reserved.